Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy
| Autor: | Sorf, Ales, Vagiannis, Dimitrios, Ahmed, Fahda, Hofman, Jakub, Ceckova, Martina |
|---|---|
| Zdroj: | In Toxicology and Applied Pharmacology 1 January 2022 434 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect